News | Stroke | November 03, 2015

New Patient Engagement Materials Released on Prevention, Treatment of AF-related Stroke

Documents, infographics and video discuss how to lower stroke risks and guide medical care

StopAfib.org, atrial fibrillation, AF-related stroke, patient engagement materials

Infographic courtesy of StopAfib.org
 

November 3, 2015 — In recognition of World Stroke Day, the patient-focused organization StopAfib.org launched a diverse set of materials for engaging and empowering people living with atrial fibrillation (AF). The materials are intended to increase the ability of patients to be engaged in their own treatment and stroke prevention decisions.

The materials are the result of a year-long initiative by a committee of the Sign Against Stroke (SAS) Task Force comprised of five patient and professional advocacy organizations to create materials to be used globally. The committee is chaired by StopAfib.org, based in the United States. Committee members include Arrythmia Alliance Argentina (Argentina), Asian Pacific Society of Cardiology (Singapore), Associacao Bate, Bate Coracao (Portugal), and Fundacja Udaru Mozgu (Poland). 

The idea originated at a global summit where member groups noted that the socioeconomic and personal burdens of AF-related stroke are high and devastating to individuals, yet many patients do not understand what atrial fibrillation is, what their stroke risk actually is and how they can prevent AF-related stroke. The task force also expressed a shared belief that many patients do not understand that it is their right to ask questions of their doctor and to participate in their treatment decisions based on the best available evidence.

The task force agreed to address these concerns through the development of a set of educational materials that could be readily translated into other languages and adapted to different cultures. They started gathering input from regional patient group summits in late 2014. 

The materials consist of five downloadable documents, two infographics and an animated video.

The five downloadable documents each focus on a specific topic:

  • About AF:  Interpreting your diagnosis and treatment options; 
  • Lower Stroke Risks:  Evidence and information to help people with AF make decisions to minimize stroke risk;
  • Questions to ask about AF:  Questions for patients to ask their healthcare providers and encourage a two-way dialogue;  
  • Getting the Best AF Care:  Guidance on how patients can communicate with physicians and advocate for their own care; and
  • Help from Family and Friends:  Ways family carers can provide support for loved ones. 

The video is three minutes long and features several messages about the dangers of AF and the importance of knowing your risks and developing a treatment plan with your doctor. The video can be made into eight mini videos of 20 to 30 seconds each for wider use and dissemination across a variety of channels.

Each of the two infographics offers facts and figures designed to enhance awareness of AF and the resulting stroke risk.

"Many people with AF are not aware of their increased risk of stroke," said Mellanie True Hills, CEO of StopAfib.org. "These materials are designed to educate patients about managing their risk and to mobilize them to become active partners in their care."

The materials are being launched globally in multiple languages, with a focus on Europe, Asia, and Latin America. They will be shared at an upcoming patient group symposium in Warsaw, Poland in November, where as many as 50 organizations from throughout Europe will be provided the materials with tools to facilitate their translation and localization.

For more information: www.stopafib.org

Related Content

A view of the EPD Solutions catheter ablation system image guidance. It displays the catheter within a pre-acquired 3D segmented CT image. The D700 system provides a real-time lesion assessment tool that predicts transmurality and permanency of lesions, pre- and immediately post-ablation.

A view of the EPD Solutions catheter ablation system image guidance. It displays the catheter within a pre-acquired 3D segmented CT image. The D700 system provides a real-time lesion assessment tool that predicts transmurality and permanency of lesions, pre- and immediately post-ablation.

News | EP Lab | June 05, 2018
June 5, 2018 — Philips Healthcare has signed an agreement to acquire EPD Solutions, a provider of image-guidance in c
A recent study shows the Baylis NRG radiofrequency (RF) Transseptal puncture catheter has a lower incidence of embolism in EP cases.
News | EP Lab | May 21, 2018
May 21, 2018 — A recent study published in Heart and Vessels has found that the use of the Baylis Medical NR
Myocarditis is an Under-recognized Etiology of Symptomatic Premature Ventricular Arrhythmia (PVCs). #HRS #HRS2018
News | EP Lab | May 18, 2018
May 18, 2018 — A significant number of patients with symptomatic premature ventricular contractions (PVCs) have under
Novel Antibiotics Can Help Lower EP Device Infection Rates. Pictured here is an ICD. Implantation of pacemakers, ICDs and the related cardiac leads opens patients to infection risk.

Implantation of pacemakers, ICDs and the related cardiac leads opens patients to infection risk.

News | EP Lab | May 17, 2018
May 10, 2018 – A new study is the first to test the clinical effectiveness of incremental peri-operative antibiotics
The Apple Watch Series 2, Samsung Galaxy Gear S3 and the Fitbit Charge 2 were all able to properly diagnose the very rapid heart beats involved in  paroxysmal supraventricular tachycardia (PSVT). #HRS2018

The Apple Watch Series 2, Samsung Galaxy Gear S3 and the Fitbit Charge 2 were all able to properly diagnose the very rapid heart beats involved in  paroxysmal supraventricular tachycardia (PSVT).  

News | EP Lab | May 16, 2018
May 16, 2018 — A new study is the first to validate the accuracy of wrist-worn wearable devices in measuring induced
LivaNova Completes Sale of Cardiac Rhythm Management (CRM - electrophysiology) Business to MicroPort Scientific
News | EP Lab | April 30, 2018
April 30, 2018 — LivaNova announced it completed the sale of its cardiac rhythm management (CRM) business to MicroPor
LivaNova Enters Binding Letter of Intent to Sell Cardiac Rhythm Management Business
News | EP Lab | January 26, 2018
January 26, 2018 — LivaNova PLC and MicroPort Scientific Corp.
Societies Detail Treatment for Patients With Ventricular Arrhythmias
News | EP Lab | October 30, 2017
The American College of Cardiology, along with the American Heart Association and the Heart Rhythm Society, published...
Baylis Medical and Siemens Co-Sponsor Transseptal Access Training Course
News | EP Lab | October 18, 2017
Baylis Medical Co. Inc. and Siemens Healthineers are co-sponsoring a first-of-its kind training program aimed at...
Spectranetics Initiates Class I Recall for Bridge Occlusion Balloon Catheter
News | EP Lab | September 27, 2017
Spectranetics is recalling its Bridge Occlusion Balloon Catheter due to the possibility of a blocked guidewire lumen in...
Overlay Init